about
Localization of α-adrenoceptors: JR Vane Medal LectureFunctional characterization of alpha(1)-adrenoceptor subtypes in human skeletal muscle resistance arteriesRole of elastin in spontaneously hypertensive rat small mesenteric artery remodellingIncreased alpha(1)- and alpha(2)-adrenoceptor-mediated contractile responses of human skeletal muscle resistance arteries in chronic limb ischemia.Cellular changes induced by chronic nitric oxide inhibition in intact rat basilar arteries revealed by confocal microscopy.Alpha1A/B-knockout mice explain the native alpha1D-adrenoceptor's role in vasoconstriction and show that its location is independent of the other alpha1-subtypesAlterations in rabbit aorta induced by types I and II pyrethroids.Evidence for involvement of alpha1D-adrenoceptors in contraction of femoral resistance arteries using knockout mice.New aspects of vascular remodelling: the involvement of all vascular cell types.Imaging the vascular wall using confocal microscopy.The alpha 1B/D-adrenoceptor knockout mouse permits isolation of the vascular alpha 1A-adrenoceptor and elucidates its relationship to the other subtypes.Previously unsuspected widespread cellular and tissue distribution of β-adrenoceptors and its relevance to drug action.Fluorescent ligand binding reveals heterogeneous distribution of adrenoceptors and 'cannabinoid-like' receptors in small arteries.Guidelines for reporting experiments involving animals: the ARRIVE guidelinesEvidence for more than one type of post-junctional alpha-adrenoceptor.Fluorescent ligands for the study of receptors.P2Y receptor-mediated Ca2+ signalling in cultured rat aortic smooth muscle cells.Investigation of alpha1-adrenoceptor subtypes mediating vasoconstriction in rabbit cutaneous resistance arteries.Insights into the functional roles of alpha(1)-adrenoceptor subtypes in mouse carotid arteries using knockout mice.Calling all pharmacologists with time to spare! We need you! Build the drug discovery knowledge base, GuidetoPharmacology.org.NOS inhibition potentiates norepinephrine but not sympathetic nerve-mediated co-transmission in resistance arteries.Comment from the Editor-in-Chief on correspondence in this issue on immuno-techniques.Endothelium in pharmacology: 30 years on.2010 re-launch of BJP.GPCR theme editorial.Direct demonstration of beta1- and evidence against beta2- and beta3-adrenoceptors, in smooth muscle cells of rat small mesenteric arteries.Drugs in sport.Continuity and change.Enhanced noradrenergic transmission in the spontaneously hypertensive rat anococcygeus muscle.Do fluorescent drugs show you more than you wanted to know?The effect of acute alteration in oxygen tension on the bronchodilator response to salbutamol in vitro and in vivo in man.Controlled hypertension, a transgenic toggle switch reveals differential mechanisms underlying vascular disease.A knockout approach indicates a minor vasoconstrictor role for vascular alpha1B-adrenoceptors in mouse.The alpha 1-adrenoceptor profile in human skeletal muscle resistance arteries in critical limb ischaemia.Effects of ketamine on central sympathetic discharge and the baroreceptor reflex during mechanical ventilation.Beta-arrestin-dependent spontaneous alpha1a-adrenoceptor endocytosis causes intracellular transportation of alpha-blockers via recycling compartments.Two "knockout" mouse models demonstrate that aortic vasodilatation is mediated via alpha2a-adrenoceptors located on the endothelium.Influence of elastin on rat small artery mechanical properties.Alpha(1D)-adrenoceptors mediate nerve and agonist-evoked contractions in mouse vas deferens: evidence obtained from knockout technology.Localization of the mouse alpha1A-adrenergic receptor (AR) in the brain: alpha1AAR is expressed in neurons, GABAergic interneurons, and NG2 oligodendrocyte progenitors.
P50
Q27022641-7106EB72-97F7-478E-A4C5-278B28DC58CEQ28367878-25D9889C-905F-420B-A675-FA4003BB1C67Q28566623-1F0F76A4-2608-4172-AA7A-ACC4CC04387FQ31719070-E4502334-A198-4748-A14B-A6EAB052D7BAQ32106376-5EC5F392-7161-4CD4-BE82-D9CFDFCEAF22Q33569502-017D0F18-1B51-4E65-BFAC-532D8DFA7524Q33969563-011C2B9B-2B22-4D51-A8A0-2803919906B1Q35545136-434AD4FC-46F3-4806-B8F6-C26883180FF9Q36127987-DBA1B36C-75BD-4F06-93A7-06DD20B1D2C9Q36893290-982C4CC7-A715-4A75-A9CE-8208DF5EBE4CQ37481315-6300A45E-3AA1-4B14-9B4A-9DA0B9B9689CQ37856497-32A96EFE-C905-4C0A-BDD4-0E537C7BB374Q39300226-C62BDEB3-B5C4-421C-AD56-5F3EBA9DB66FQ39512979-91098081-C5C5-4C50-9E23-0B8929A37C02Q40128697-21768572-4BD6-4460-8C43-EAF81D685B94Q41304851-5094DE81-7C16-4E51-B347-DBD37EDF20EEQ41809101-797CA93E-3F12-4301-99DF-6908D2498260Q42036027-E95F461B-F35E-45E5-93AE-DE5882C640DAQ42118714-4CB8AE21-164F-424D-B63C-BEB220E79D3AQ42388682-38E5A48D-08DF-4018-8DEF-A4AB84184998Q42484124-998D950F-527B-4433-BED4-2BB7F2E94FFAQ42843677-98D17AAC-F056-4687-BE47-3732B7682884Q42850138-BD54B3DC-5BC5-4F0A-81D2-5BC4CE74F992Q42914162-E269A348-47A7-462D-906A-F14B049C5565Q42951309-68822A85-DA71-486A-8054-2E395121E286Q43054854-FD7B5A56-FF39-4715-9AA4-EB1DD37B5B92Q43103569-B26FC386-D889-4677-BDD8-54D151F93DF3Q43110539-4354B083-1DB5-4691-AB74-3221EE08C2F0Q43263214-9C77BCF9-136F-4EC9-BA59-DA58E270B004Q43263380-9F8078AD-937E-40D4-A0C3-0D7225A0C279Q43556309-0CCBA7F7-9670-4F8C-B2DE-2BE6775C561AQ43670943-7203CFB9-8E2B-4F39-BB88-1958C6622B98Q43990208-800C56BC-56F2-41D3-B68A-44DD724556B3Q44301917-00785247-EF8D-4D15-8AD5-FE6CAAEF758CQ44757831-CCC88E5A-D217-4ED3-B7AC-38FC7F17A117Q45207503-DC6F1F11-07DD-4830-864C-1B08C7A1DA82Q46477327-3377DFEE-6C48-41A4-96D3-778E7E15672EQ46487958-5BEE2926-FC52-4E10-A671-E5CCB9FF470EQ46504235-0B73DA99-C1E2-422A-9F99-66E3BA657DAAQ48536746-E125D917-547E-49B0-85FE-60F524C69CA5
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
John C. McGrath
@ast
John C. McGrath
@en
John C. McGrath
@es
John C. McGrath
@nl
John C. McGrath
@sl
type
label
John C. McGrath
@ast
John C. McGrath
@en
John C. McGrath
@es
John C. McGrath
@nl
John C. McGrath
@sl
altLabel
Ian McGrath
@en
J.C. McGrath
@en
John Christie McGrath
@en
prefLabel
John C. McGrath
@ast
John C. McGrath
@en
John C. McGrath
@es
John C. McGrath
@nl
John C. McGrath
@sl
P1053
G-6485-2012
P106
P1153
7402677729
P21
P31
P3829
P496
0000-0002-5276-0381